<li>abobotulinumtoxina<p>abobotulinumtoxina and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>aclidinium<p>diphenhydramine and aclidinium both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>albuterol<p>diphenhydramine increases and albuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>alfentanil<p>diphenhydramine and alfentanil both increase  sedation. Use Caution/Monitor.</p></li><li>alprazolam<p>diphenhydramine and alprazolam both increase  sedation. Use Caution/Monitor.</p></li><li>amantadine<p>diphenhydramine, amantadine. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Potential for increased anticholinergic adverse effects.</p></li><li>ambenonium<p>ambenonium increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>amisulpride<p>diphenhydramine and amisulpride both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of amisulpride by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of amisulpride by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>amisulpride increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>amitriptyline<p>diphenhydramine and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely.<span><br><br></span>diphenhydramine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>amobarbital<p>diphenhydramine and amobarbital both increase  sedation. Use Caution/Monitor.</p></li><li>amoxapine<p>diphenhydramine and amoxapine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and amoxapine both increase  sedation. Use Caution/Monitor.</p></li><li>anticholinergic/sedative combos<p>anticholinergic/sedative combos and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>apomorphine<p>diphenhydramine and apomorphine both increase  sedation. Use Caution/Monitor.</p></li><li>arformoterol<p>diphenhydramine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>aripiprazole<p>diphenhydramine and aripiprazole both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of aripiprazole by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of aripiprazole by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>aripiprazole increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>armodafinil<p>diphenhydramine increases and armodafinil decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>atomoxetine<p>diphenhydramine will increase the level or effect of atomoxetine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>atracurium<p>atracurium and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>atropine<p>atropine and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>atropine iv/im<p>atropine iv/im and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>azelastine<p>azelastine and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>baclofen<p>diphenhydramine and baclofen both increase  sedation. Use Caution/Monitor.</p></li><li>bambuterol<p>diphenhydramine increases and bambuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>belladonna alkaloids<p>belladonna alkaloids and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>belladonna and opium<p>diphenhydramine and belladonna and opium both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and belladonna and opium both increase  sedation. Use Caution/Monitor.</p></li><li>benperidol<p>diphenhydramine and benperidol both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of benperidol by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of benperidol by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>benperidol increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>benzphetamine<p>diphenhydramine increases and benzphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>benztropine<p>benztropine and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor. Additive anticholinergic adverse effects may be seen with concurrent use. </p></li><li>bethanechol<p>bethanechol increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>brexpiprazole<p>diphenhydramine will increase the level or effect of brexpiprazole by  affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Administer a quarter of brexpiprazole dose if coadministered with a moderate CYP2D6 inhibitor PLUS a strong/moderate CYP3A4 inhibitor. </p></li><li>brompheniramine<p>brompheniramine and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>buclizine<p>buclizine and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>buprenorphine<p>diphenhydramine and buprenorphine both increase  sedation. Use Caution/Monitor.</p></li><li>buprenorphine buccal<p>diphenhydramine and buprenorphine buccal both increase  sedation. Use Caution/Monitor.</p></li><li>butabarbital<p>diphenhydramine and butabarbital both increase  sedation. Use Caution/Monitor.</p></li><li>butalbital<p>diphenhydramine and butalbital both increase  sedation. Use Caution/Monitor.</p></li><li>butorphanol<p>diphenhydramine and butorphanol both increase  sedation. Use Caution/Monitor.</p></li><li>caffeine<p>diphenhydramine increases and caffeine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>carbachol<p>carbachol increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>carbinoxamine<p>carbinoxamine and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>carisoprodol<p>diphenhydramine and carisoprodol both increase  sedation. Use Caution/Monitor.</p></li><li>carvedilol<p>diphenhydramine will increase the level or effect of carvedilol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>cevimeline<p>cevimeline increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>chloral hydrate<p>diphenhydramine and chloral hydrate both increase  sedation. Use Caution/Monitor.</p></li><li>chlordiazepoxide<p>diphenhydramine and chlordiazepoxide both increase  sedation. Use Caution/Monitor.</p></li><li>chlorpheniramine<p>chlorpheniramine and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>chlorpromazine<p>diphenhydramine and chlorpromazine both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of chlorpromazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of chlorpromazine by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>chlorpromazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>chlorzoxazone<p>diphenhydramine and chlorzoxazone both increase  sedation. Use Caution/Monitor.</p></li><li>cinnarizine<p>cinnarizine and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>cisatracurium<p>cisatracurium and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>clemastine<p>clemastine and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>clobazam<p>diphenhydramine, clobazam. Other (see comment). Use Caution/Monitor. 
Comment: Concomitant administration can increase the potential for CNS effects (e.g., increased sedation or respiratory depression).</p></li><li>clomethiazole<p>diphenhydramine and clomethiazole both increase  sedation. Use Caution/Monitor.</p></li><li>clomipramine<p>diphenhydramine will increase the level or effect of clomipramine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and clomipramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and clomipramine both increase  sedation. Use Caution/Monitor.</p></li><li>clonazepam<p>diphenhydramine and clonazepam both increase  sedation. Use Caution/Monitor.</p></li><li>clorazepate<p>diphenhydramine and clorazepate both increase  sedation. Use Caution/Monitor.</p></li><li>clozapine<p>diphenhydramine and clozapine both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of clozapine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of clozapine by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>clozapine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>codeine<p>diphenhydramine decreases effects of codeine by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Prevents conversion of codeine to its active metabolite morphine.<span><br><br></span>diphenhydramine and codeine both increase  sedation. Use Caution/Monitor.</p></li><li>cyclizine<p>cyclizine and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>cyclizine and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>cyclobenzaprine<p>cyclobenzaprine and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and cyclobenzaprine both increase  sedation. Use Caution/Monitor.</p></li><li>cyproheptadine<p>cyproheptadine and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>dantrolene<p>diphenhydramine and dantrolene both increase  sedation. Use Caution/Monitor.</p></li><li>darifenacin<p>darifenacin and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>desflurane<p>desflurane and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>desipramine<p>diphenhydramine will increase the level or effect of desipramine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and desipramine both increase  sedation. Use Caution/Monitor.</p></li><li>dexchlorpheniramine<p>dexchlorpheniramine and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>dexfenfluramine<p>diphenhydramine increases and dexfenfluramine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dexmedetomidine<p>diphenhydramine and dexmedetomidine both increase  sedation. Use Caution/Monitor.</p></li><li>dexmethylphenidate<p>diphenhydramine increases and dexmethylphenidate decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dextroamphetamine<p>diphenhydramine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dextromoramide<p>diphenhydramine and dextromoramide both increase  sedation. Use Caution/Monitor.</p></li><li>diamorphine<p>diphenhydramine and diamorphine both increase  sedation. Use Caution/Monitor.</p></li><li>diazepam<p>diphenhydramine and diazepam both increase  sedation. Use Caution/Monitor.</p></li><li>dicyclomine<p>dicyclomine and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>diethylpropion<p>diphenhydramine increases and diethylpropion decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>difenoxin hcl<p>diphenhydramine and difenoxin hcl both increase  sedation. Use Caution/Monitor.</p></li><li>dimenhydrinate<p>dimenhydrinate and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>diphenoxylate hcl<p>diphenhydramine and diphenoxylate hcl both increase  sedation. Use Caution/Monitor.</p></li><li>dipipanone<p>diphenhydramine and dipipanone both increase  sedation. Use Caution/Monitor.</p></li><li>distigmine<p>distigmine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dobutamine<p>diphenhydramine increases and dobutamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>donepezil<p>donepezil increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dopamine<p>diphenhydramine increases and dopamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dopexamine<p>diphenhydramine increases and dopexamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dosulepin<p>diphenhydramine and dosulepin both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and dosulepin both increase  sedation. Use Caution/Monitor.</p></li><li>doxepin<p>diphenhydramine and doxepin both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and doxepin both increase  sedation. Use Caution/Monitor.</p></li><li>doxylamine<p>diphenhydramine and doxylamine both increase  sedation. Use Caution/Monitor.</p></li><li>droperidol<p>diphenhydramine and droperidol both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of droperidol by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of droperidol by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>droperidol increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>duloxetine<p>diphenhydramine will increase the level or effect of duloxetine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>echothiophate iodide<p>echothiophate iodide increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>edrophonium<p>edrophonium increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>enflurane<p>enflurane and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>ephedrine<p>diphenhydramine increases and ephedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ephedrine (pulmonary)<p>diphenhydramine increases and ephedrine (pulmonary) decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.  .</p></li><li>epinephrine<p>diphenhydramine increases and epinephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>epinephrine racemic<p>diphenhydramine increases and epinephrine racemic decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>estazolam<p>diphenhydramine and estazolam both increase  sedation. Use Caution/Monitor.</p></li><li>ethanol<p>diphenhydramine and ethanol both increase  sedation. Use Caution/Monitor.</p></li><li>etomidate<p>etomidate and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>fenfluramine<p>diphenhydramine increases and fenfluramine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>fentanyl<p>fentanyl, diphenhydramine.
Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.</p></li><li>fentanyl intranasal<p>fentanyl intranasal, diphenhydramine.
Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.</p></li><li>fentanyl iontophoretic transdermal system<p>fentanyl iontophoretic transdermal system, diphenhydramine.
Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.</p></li><li>fentanyl transdermal<p>fentanyl transdermal, diphenhydramine.
Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.</p></li><li>fentanyl transmucosal<p>fentanyl transmucosal, diphenhydramine.
Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.</p></li><li>fesoterodine<p>diphenhydramine and fesoterodine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>flavoxate<p>diphenhydramine and flavoxate both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>flecainide<p>diphenhydramine will increase the level or effect of flecainide by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>flibanserin<p>diphenhydramine and flibanserin both increase  sedation. Modify Therapy/Monitor Closely. Risk for sedation increased if flibanserin is coadministration with other CNS depressants.</p></li><li>fluphenazine<p>diphenhydramine and fluphenazine both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of fluphenazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of fluphenazine by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>fluphenazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>flurazepam<p>diphenhydramine and flurazepam both increase  sedation. Use Caution/Monitor.</p></li><li>formoterol<p>diphenhydramine increases and formoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>fospropofol<p>diphenhydramine and fospropofol both increase  sedation. Use Caution/Monitor.</p></li><li>galantamine<p>galantamine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>glycopyrrolate<p>diphenhydramine and glycopyrrolate both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>glycopyrrolate inhaled<p>diphenhydramine and glycopyrrolate inhaled both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>gotu kola<p>gotu kola increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.</p></li><li>haloperidol<p>diphenhydramine will increase the level or effect of haloperidol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and haloperidol both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of haloperidol by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of haloperidol by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>haloperidol increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>hawthorn<p>hawthorn increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.</p></li><li>henbane<p>diphenhydramine and henbane both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>hexobarbital<p>diphenhydramine and hexobarbital both increase  sedation. Use Caution/Monitor.</p></li><li>homatropine<p>diphenhydramine and homatropine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>hops<p>hops increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.</p></li><li>huperzine a<p>huperzine a increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>hyaluronidase<p>diphenhydramine decreases effects of hyaluronidase by Other (see comment). Use Caution/Monitor. 
Comment: Antihistamines, when given in large systemic doses, may render tissues partially resistant to the action of hyaluronidase. Patients may require larger amounts of hyaluronidase for equivalent dispersing effect.</p></li><li>hydrocodone<p>diphenhydramine will increase the level or effect of hydrocodone by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and hydrocodone both increase  sedation. Use Caution/Monitor.</p></li><li>hydromorphone<p>diphenhydramine will increase the level or effect of hydromorphone by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and hydromorphone both increase  sedation. Use Caution/Monitor.</p></li><li>hydroxyzine<p>diphenhydramine and hydroxyzine both increase  sedation. Use Caution/Monitor.</p></li><li>hyoscyamine<p>diphenhydramine and hyoscyamine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>hyoscyamine spray<p>diphenhydramine and hyoscyamine spray both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>iloperidone<p>diphenhydramine will increase the level or effect of iloperidone by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and iloperidone both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of iloperidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of iloperidone by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>iloperidone increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>imipramine<p>diphenhydramine will increase the level or effect of imipramine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and imipramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and imipramine both increase  sedation. Use Caution/Monitor.</p></li><li>incobotulinumtoxina<p>incobotulinumtoxina and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>ipratropium<p>diphenhydramine and ipratropium both decrease  cholinergic effects/transmission. Use Caution/Monitor. Due to the poor systemic absorption of ipratropium,  interaction unlikely at regularly recommended dosages.</p></li><li>isoproterenol<p>diphenhydramine increases and isoproterenol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>kava<p>kava increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.</p></li><li>ketamine<p>ketamine and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>ketotifen, ophthalmic<p>diphenhydramine and ketotifen, ophthalmic both increase  sedation. Use Caution/Monitor.</p></li><li>levalbuterol<p>diphenhydramine increases and levalbuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>levodopa<p>diphenhydramine, levodopa. Other (see comment). Use Caution/Monitor. 
Comment: Anticholinergic agents may enhance the therapeutic effects of levodopa; however, anticholinergic agents can exacerbate tardive dyskinesia. In high dosage, anticholinergics may decrease the effects of levodopa by delaying its GI absorption. .</p></li><li>levorphanol<p>diphenhydramine and levorphanol both increase  sedation. Use Caution/Monitor.</p></li><li>lisdexamfetamine<p>diphenhydramine increases and lisdexamfetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>lofepramine<p>diphenhydramine will increase the level or effect of lofepramine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and lofepramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and lofepramine both increase  sedation. Use Caution/Monitor.</p></li><li>lofexidine<p>diphenhydramine and lofexidine both increase  sedation. Use Caution/Monitor.</p></li><li>loprazolam<p>diphenhydramine and loprazolam both increase  sedation. Use Caution/Monitor.</p></li><li>lorazepam<p>diphenhydramine and lorazepam both increase  sedation. Use Caution/Monitor.</p></li><li>lormetazepam<p>diphenhydramine and lormetazepam both increase  sedation. Use Caution/Monitor.</p></li><li>loxapine<p>diphenhydramine and loxapine both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of loxapine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of loxapine by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>loxapine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>loxapine inhaled<p>loxapine inhaled increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.<span><br><br></span>diphenhydramine and loxapine inhaled both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of loxapine inhaled by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>lurasidone<p>lurasidone, diphenhydramine.
Either increases toxicity of the other by Other (see comment). Use Caution/Monitor. 
Comment: Potential for increased CNS depressant effects when used concurrently; monitor for increased adverse effects and toxicity.</p></li><li>maprotiline<p>diphenhydramine and maprotiline both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and maprotiline both increase  sedation. Use Caution/Monitor.</p></li><li>marijuana<p>diphenhydramine and marijuana both increase  sedation. Use Caution/Monitor.</p></li><li>meclizine<p>diphenhydramine and meclizine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>melatonin<p>diphenhydramine and melatonin both increase  sedation. Use Caution/Monitor.</p></li><li>mepenzolate<p>diphenhydramine and mepenzolate both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>meperidine<p>diphenhydramine and meperidine both increase  sedation. Use Caution/Monitor.</p></li><li>mephobarbital<p>diphenhydramine and mephobarbital both increase  sedation. Use Caution/Monitor.</p></li><li>meprobamate<p>diphenhydramine and meprobamate both increase  sedation. Use Caution/Monitor.</p></li><li>metaproterenol<p>diphenhydramine increases and metaproterenol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>metaxalone<p>diphenhydramine and metaxalone both increase  sedation. Use Caution/Monitor.</p></li><li>methadone<p>diphenhydramine and methadone both increase  sedation. Use Caution/Monitor.</p></li><li>methamphetamine<p>diphenhydramine will increase the level or effect of methamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine increases and methamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>methocarbamol<p>diphenhydramine and methocarbamol both increase  sedation. Use Caution/Monitor.</p></li><li>methscopolamine<p>diphenhydramine and methscopolamine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>methylenedioxymethamphetamine<p>diphenhydramine increases and methylenedioxymethamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>methylphenidate<p>diphenhydramine increases and methylphenidate decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>metoprolol<p>diphenhydramine will increase the level or effect of metoprolol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>mexiletine<p>diphenhydramine will increase the level or effect of mexiletine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>mianserin<p>diphenhydramine and mianserin both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and mianserin both increase  sedation. Use Caution/Monitor.</p></li><li>mibefradil<p>diphenhydramine will increase the level or effect of mibefradil by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>midazolam<p>diphenhydramine and midazolam both increase  sedation. Use Caution/Monitor.</p></li><li>midodrine<p>diphenhydramine increases and midodrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>mirtazapine<p>diphenhydramine and mirtazapine both increase  sedation. Use Caution/Monitor.</p></li><li>modafinil<p>diphenhydramine increases and modafinil decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>morphine<p>diphenhydramine will increase the level or effect of morphine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and morphine both increase  sedation. Use Caution/Monitor.</p></li><li>motherwort<p>diphenhydramine and motherwort both increase  sedation. Use Caution/Monitor.</p></li><li>moxonidine<p>diphenhydramine and moxonidine both increase  sedation. Use Caution/Monitor.</p></li><li>nabilone<p>diphenhydramine and nabilone both increase  sedation. Use Caution/Monitor.</p></li><li>nalbuphine<p>diphenhydramine and nalbuphine both increase  sedation. Use Caution/Monitor.</p></li><li>nebivolol<p>diphenhydramine will increase the level or effect of nebivolol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>neostigmine<p>neostigmine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>norepinephrine<p>diphenhydramine increases and norepinephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>nortriptyline<p>diphenhydramine will increase the level or effect of nortriptyline by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and nortriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and nortriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>olanzapine<p>diphenhydramine and olanzapine both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of olanzapine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of olanzapine by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>olanzapine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>onabotulinumtoxina<p>onabotulinumtoxina and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>opium tincture<p>diphenhydramine and opium tincture both increase  sedation. Use Caution/Monitor.</p></li><li>orphenadrine<p>diphenhydramine and orphenadrine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and orphenadrine both increase  sedation. Use Caution/Monitor.</p></li><li>ospemifene<p>diphenhydramine, ospemifene.
Either increases levels of the other by plasma protein binding competition. Modify Therapy/Monitor Closely.</p></li><li>oxazepam<p>diphenhydramine and oxazepam both increase  sedation. Use Caution/Monitor.</p></li><li>oxybutynin<p>diphenhydramine and oxybutynin both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>oxybutynin topical<p>diphenhydramine and oxybutynin topical both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>oxybutynin transdermal<p>diphenhydramine and oxybutynin transdermal both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>oxycodone<p>diphenhydramine will increase the level or effect of oxycodone by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and oxycodone both increase  sedation. Use Caution/Monitor.</p></li><li>oxymorphone<p>diphenhydramine will increase the level or effect of oxymorphone by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and oxymorphone both increase  sedation. Use Caution/Monitor.</p></li><li>paliperidone<p>diphenhydramine and paliperidone both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of paliperidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of paliperidone by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>paliperidone increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>pancuronium<p>diphenhydramine and pancuronium both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>papaveretum<p>diphenhydramine and papaveretum both increase  sedation. Use Caution/Monitor.</p></li><li>papaverine<p>diphenhydramine and papaverine both increase  sedation. Use Caution/Monitor.</p></li><li>passion flower<p>passion flower increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.</p></li><li>pentazocine<p>diphenhydramine and pentazocine both increase  sedation. Use Caution/Monitor.</p></li><li>pentobarbital<p>diphenhydramine and pentobarbital both increase  sedation. Use Caution/Monitor.</p></li><li>perampanel<p>perampanel and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>perphenazine<p>diphenhydramine and perphenazine both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of perphenazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of perphenazine by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>perphenazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>phendimetrazine<p>diphenhydramine increases and phendimetrazine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>phenelzine<p>phenelzine increases effects of diphenhydramine by Other (see comment). Modify Therapy/Monitor Closely. 
Comment: Coadministration of phenelzine and antihistamines may result in additive CNS depressant effects. MAO inhibitors also prolong and intensify anticholinergic effects of antihistamines. .</p></li><li>phenobarbital<p>diphenhydramine and phenobarbital both increase  sedation. Use Caution/Monitor.</p></li><li>phentermine<p>diphenhydramine increases and phentermine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>phenylephrine<p>diphenhydramine increases and phenylephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>phenylephrine po<p>diphenhydramine increases and phenylephrine po decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.  .</p></li><li>pholcodine<p>diphenhydramine and pholcodine both increase  sedation. Use Caution/Monitor.</p></li><li>physostigmine<p>physostigmine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>pilocarpine<p>pilocarpine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>pilocarpine ophthalmic<p>pilocarpine ophthalmic increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>pimozide<p>diphenhydramine and pimozide both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of pimozide by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of pimozide by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>pimozide increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>pirbuterol<p>diphenhydramine increases and pirbuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>pralidoxime<p>diphenhydramine and pralidoxime both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>primidone<p>diphenhydramine and primidone both increase  sedation. Use Caution/Monitor.</p></li><li>prochlorperazine<p>diphenhydramine and prochlorperazine both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of prochlorperazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of prochlorperazine by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>prochlorperazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>promethazine<p>diphenhydramine and promethazine both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of promethazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of promethazine by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>promethazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>propafenone<p>diphenhydramine will increase the level or effect of propafenone by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>propantheline<p>diphenhydramine and propantheline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>propofol<p>propofol and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>propranolol<p>diphenhydramine will increase the level or effect of propranolol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>propylhexedrine<p>diphenhydramine increases and propylhexedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>protriptyline<p>diphenhydramine and protriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and protriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>pseudoephedrine<p>diphenhydramine increases and pseudoephedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>pyridostigmine<p>pyridostigmine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>quazepam<p>diphenhydramine and quazepam both increase  sedation. Use Caution/Monitor.</p></li><li>quetiapine<p>diphenhydramine and quetiapine both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of quetiapine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of quetiapine by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>quetiapine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>ramelteon<p>diphenhydramine and ramelteon both increase  sedation. Use Caution/Monitor.</p></li><li>rapacuronium<p>diphenhydramine and rapacuronium both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>rimabotulinumtoxinb<p>rimabotulinumtoxinb and diphenhydramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>risperidone<p>diphenhydramine and risperidone both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of risperidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of risperidone by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>risperidone increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>rocuronium<p>diphenhydramine and rocuronium both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>salmeterol<p>diphenhydramine increases and salmeterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>scopolamine<p>diphenhydramine and scopolamine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>scullcap<p>diphenhydramine and scullcap both increase  sedation. Use Caution/Monitor.</p></li><li>secobarbital<p>diphenhydramine and secobarbital both increase  sedation. Use Caution/Monitor.</p></li><li>sertindole<p>diphenhydramine will increase the level or effect of sertindole by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>diphenhydramine and sertindole both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of sertindole by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of sertindole by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>sertindole increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>sevoflurane<p>sevoflurane and diphenhydramine both increase  sedation. Use Caution/Monitor.</p></li><li>shepherd's purse<p>diphenhydramine and shepherd's purse both increase  sedation. Use Caution/Monitor.</p></li><li>solifenacin<p>diphenhydramine and solifenacin both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>succinylcholine<p>succinylcholine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>sufentanil<p>diphenhydramine and sufentanil both increase  sedation. Use Caution/Monitor.</p></li><li>sulpiride<p>diphenhydramine and sulpiride both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of sulpiride by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of sulpiride by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>sulpiride increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>tacrine<p>tacrine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>tamoxifen<p>diphenhydramine decreases effects of tamoxifen by decreasing metabolism. Use Caution/Monitor. Inhibition of CYP2D6 metabolism to tamoxifen's active metabolite, endoxifen.</p></li><li>tamsulosin<p>diphenhydramine increases levels of tamsulosin by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>tapentadol<p>diphenhydramine and tapentadol both increase  sedation. Use Caution/Monitor.</p></li><li>temazepam<p>diphenhydramine and temazepam both increase  sedation. Use Caution/Monitor.</p></li><li>terbutaline<p>diphenhydramine increases and terbutaline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>terfenadine<p>diphenhydramine and terfenadine both increase  sedation. Use Caution/Monitor.</p></li><li>thioridazine<p>diphenhydramine and thioridazine both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of thioridazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of thioridazine by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>thioridazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>thiothixene<p>diphenhydramine and thiothixene both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of thiothixene by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of thiothixene by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>thiothixene increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>timolol<p>diphenhydramine will increase the level or effect of timolol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>tiotropium<p>diphenhydramine and tiotropium both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>tolterodine<p>diphenhydramine and tolterodine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>topiramate<p>diphenhydramine and topiramate both increase  sedation. Modify Therapy/Monitor Closely.</p></li><li>tramadol<p>diphenhydramine decreases effects of tramadol by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Decreased conversion of tramadol to active metabolite.<span><br><br></span>diphenhydramine and tramadol both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases effects of tramadol by decreasing metabolism. Use Caution/Monitor. Decreased conversion of tramadol to active metabolite.</p></li><li>trazodone<p>diphenhydramine and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>triazolam<p>diphenhydramine and triazolam both increase  sedation. Use Caution/Monitor.</p></li><li>triclofos<p>diphenhydramine and triclofos both increase  sedation. Use Caution/Monitor.</p></li><li>trifluoperazine<p>diphenhydramine and trifluoperazine both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of trifluoperazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of trifluoperazine by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>trifluoperazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>trihexyphenidyl<p>diphenhydramine and trihexyphenidyl both decrease  cholinergic effects/transmission. Use Caution/Monitor. Potential for additive anticholinergic effects.</p></li><li>trimipramine<p>diphenhydramine and trimipramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>diphenhydramine and trimipramine both increase  sedation. Use Caution/Monitor.</p></li><li>trospium chloride<p>diphenhydramine and trospium chloride both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>tubocurarine<p>diphenhydramine and tubocurarine both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>valerian<p>valerian increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.</p></li><li>vecuronium<p>diphenhydramine and vecuronium both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>xylometazoline<p>diphenhydramine increases and xylometazoline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>yohimbine<p>diphenhydramine increases and yohimbine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ziconotide<p>diphenhydramine and ziconotide both increase  sedation. Use Caution/Monitor.</p></li><li>ziprasidone<p>diphenhydramine and ziprasidone both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of ziprasidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of ziprasidone by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>ziprasidone increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li><li>zotepine<p>diphenhydramine and zotepine both increase  sedation. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of zotepine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>diphenhydramine decreases levels of zotepine by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>zotepine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.</p></li>